Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects

Psychiatry Research

Volumn 71, Issue 3, 1997, Pages 137-149

  Pandey, Ghanshyam N ^a,d   Conley, Robert R ^b   Pandey, Subhash C ^a   Goel, Sudhir ^a   Roberts, Rosalinda C ^b   Tamminga, Carol A ^b   Chute, Dennis ^c   Smialek, John ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Psychiatric Institute   (United States)

Author keywords

Benzodiazepine receptors; Neuroleptic drugs; Schizophrenia; Suicide

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ATROPINE; BENZODIAZEPINE RECEPTOR; BUTALBITAL; CHLORODIFLUOROMETHANE; CHLORPROMAZINE; CODEINE; DEXTROPROPOXYPHENE; DIPHENHYDRAMINE; DOXEPIN; FLUMAZENIL; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; LIDOCAINE; LITHIUM; MORPHINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PARACETAMOL; THIORIDAZINE; TRIFLUOPERAZINE; TRITIUM; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; FEMALE; GABAERGIC SYSTEM; HUMAN; LIGAND BINDING; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; SCHIZOPHRENIA; SUICIDE;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FLUMAZENIL; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; SCHIZOPHRENIA; SUICIDE;

EID: 0030874314     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)00060-7     Document Type: Article

References (45)

1. A receptor binding in superficial layers of cingulate cortex in schizophrenics. Journal of Neuroscience 12, 924-929.
2. A receptor subtypes from pharmacology to molecular biology. FASEB Journal 5, 2916-2923.
3. Burt, D.R., Creese, I., Snyder, S.H., 1977. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196, 326-328.
4. A/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Research 460, 114-123.
5. Costa, E., Guidotti, A., 1996. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends in Pharmacological Sciences 17, 192-200.
6. Garbutt, J.C., Van Kammen, D.P., 1983. The interaction between GABA and dopamine: implications for schizophrenia. Schizophrenia Bulletin 9, 336-353.
7. Gavish, M., Weizmann, R., Becker, D., Tanne, Z., 1988. Effect of chronic haloperidol treatment on peripheral benzodiazepine binding sites in cerebral cortex of rats. Journal of Neural Transmission 74, 109-116.
8. Gerner, R.H., Fairbanks, L., Anderson, G.M., Young, J.G., Scheinin, M., Linnoila, M., Hare, T.A., Shaywitz, B.A., Cohen, D.J., 1984. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. American Journal of Psychiatry 141, 1533-1540.
9. Giardino, L., Zanni, M., Velardo, A., Amato, G., Calza, L., 1993. Effect of sertraline treatment on benzodiazepine receptors in rat brain. Journal of Neural Transmission 94, 31-41.
10. Guidotti, A., Baraldi, M., Schwartz, J.P., Costa, E., 1979. Molecular mechanisms regulating the interactions between the benzodiazepines and GABA receptors in the central nervous system. Pharmacology, Biochemistry and Behavior 10, 803-807.
11. Haefely, W.E., Kyburz, E., Gerecke, M., Mohler, H., 1985. Recent advances in the molecular pharmacology of the benzodiazepine receptors and in the structure activity relationships of their agonists and antagonists. Advanced Drug Research 14, 165-322.
12. Haefely, W.E., 1989. Pharmacology of the benzodiazepine receptor. European Archives of Psychiatry and Neurological Science 238, 294-301.
13. Haefely, W.E., Martin, J.R., Richards, J.G., Schoch, P., 1993. The multiplicity of actions of benzodiazepine receptor ligands. Canadian Journal of Psychiatry 38, S102-S107.
14. Hanada, S., Mita, T., Nashimo, N., Tanaka, C., 1987. Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sciences 40, 258-266.
15. Hunkeler, W., Mohler, H., Pieri, L., Bonetti, E.P., Cumin, R., Schaffner, R., Haefely, W., 1981. Selective antagonists of benzodiazepines. Nature 290, 574-576.
16. A receptors in rat brain following chronic antidepressant drug administration. Biochemical Pharmacology 36, 4173-4175.
17. Kiuchi, Y., Kobayashi, T., Takeuchi, J., Shimizu, H., Ogata, H., Toru, M., 1989. Benzodiazepine receptors increase in postmortem brain of chronic schizophrenics. European Archives of Psychiatry and Neurological Science 239, 71-78.
18. 3H]RO15-1788 binding to benzodiazepine receptors in human postmortem brain homogenates. Journal of Neurochemistry 55, 1310-1315.
19. 2 receptors in the striatum and frontal cortex following chronic administration of haloperidol. Neuropharmacology 26, 481-483.
20. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
21. Maloteaux, J.-M., Octave, J.-N., Vanisberg, M.-A., Kollmann, P., Ackermans, A., Laterre, C., 1988. Benzodiazepine receptors in human brain: characterization, subcellular localization, and solubilization. Progress in Neuro-Psychopharmacology and Biological Psychiatry 12, 773-782.
22. Manchon, M., Kopp, N., Rouzioux, J.J., Lecestre, D., Deluermoz, S., Miachon, S., 1987. Benzodiazepine receptors and neurotransmitter studies in the brain of suicides. Life Sciences 41, 2623-2630.
23. Martin, I.L., 1987. The benzodiazepines and their receptors: 25 years of progress. Neuropharmacology 26, 957-970.
24. 2A binding sites in frontal cortex of suicide victims. Journal of Neural Transmission 85, 181-194.
25. McPherson, G.A., 1985. Analysis of radioligand binding experiments: a collection of computer programs for IBM PC. Journal of Pharmacological Methods 14, 213-228.
26. Medina, J.H., Novas, M.L., Wolfman, C.N.V., Levi DeStein, M., DeRobertis, E., 1983. Benzodiazepine receptors in rat cerebral cortex and hippocampus undergo rapid and reversible changes after acute stress. Neuroscience 9, 331-335.
27. Mohler, H., Richards, H.G., 1981. Agonist and antagonist benzodiazepine receptor interaction. Nature 294, 763-775.
28. Norman, T.R., Burrows, G.D., 1986. Anxiety and the benzodiazepine receptor. Progress in Brain Research 65, 73-90.
29. Olsen, R.W., 1985. GABA-benzodiazepine-barbituate receptor interactions. Journal of Neurochemistry 37, 1-13.
30. a receptors. FASEB Journal 4, 1469-1480.
31. Reynolds, G.P., Stroud, D., 1993. Hippocampal benzodiazepine receptors in schizophrenia. Journal of Neural Transmission 93, 151-155.
32. Rochet, E., Kopp, N., Deluermoz, S., Debilly, G., Miachon, S., 1992. Benzodiazepine binding sites and their modulators in hippocampus of violent suicide victims. Biological Psychiatry 32, 922-931.
33. Salzman, S., Endicott, J., Clayton, P., Winoker, G., 1983. Diagnostic Evaluation after Death (DEAD). National Institute of Mental Health, Neuroscience Research Branch, Rockville, MD.
34. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1992. Structured Clinical Interview for DSM-III-R. I: History, rationale, and description. Archives of General Psychiatry 49, 624-629.
35. 3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses? Neurochemistry Research 18, 219-223.
36. Stocks, G.M., Cheetham, S.C., Crompton, M.R., Katona, C.L.E., Horton, R.W., 1990. Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims. Journal of Affective Disorders 18, 11-15.
37. Suranyi-Cadotte, B.E., Bodnoff, S.R., Welner, S.A., 1990. Antidepressant-anxiolytic interactions: involvement of the benzodiazepine-GABA and serotonin systems. Progress in Neuro-Psychopharmacology and Biological Psychiatry 14, 633-654.
38. Suranyi-Cadotte, B.E., Dam, T.V., Quirion, R., 1984. Antidepressant-anxiolytic interaction: decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants. European Journal of Pharmacology 106, 673-675.
39. Tallman, J.F., Thomas, J.W., Gallager, D.W., 1978. GABAergic modulation of benzodiazepine binding site sensitivity. Nature 274, 383-385.
40. Todd, K.G., McManus, D.J., Baker, G.B., 1995. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine 2A receptors without affecting benzodiazepine binding sites in rat brain. Cellular and Molecular Neurobiology 15, 361-370.
41. Van Kammen, D.P., Sternberg, D.S., Hare, T., Walters, R., Bunney, W.E., 1989. CSF levels of gamma-amino butyric acid in schizophrenia. Archives of General Psychiatry 39, 91-97.
42. A and benzodiazepine receptor binding in the hippocampal formation of schizophrenics. Abstract, Society for Neuroscience, November, 2127.
43. Weizman, R., Tanne, Z., Granek, M., Karp, L., Golomb, M., Tyano, S., Gavish, M., 1987. Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. European Journal of Pharmacology 138, 289-292.
44. Yakushizi, T., Shirasaki, T., Munakata, M., Hisata, A., Akaike, N., 1993. Differential population of type I and type II benzodiazepine receptors in mammalian CNS neurons. British Journal of Pharmacology 109, 819-825.
45. Zimmer, R., Teelken, A.W., Meier, K.D., Ackenheil, M., Zander, K.J., 1981. Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs. Progress in Neuropsychopharmacology 4, 613-620.